Cairn Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Cairn Biosciences's estimated annual revenue is currently $1.7M per year.
- Cairn Biosciences's estimated revenue per employee is $155,000
Employee Data
- Cairn Biosciences has 11 Employees.
- Cairn Biosciences grew their employee count by 0% last year.
Cairn Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Contract Recruiter | Reveal Email/Phone |
2 | Data Science Intern | Reveal Email/Phone |
3 | PhD Fellow | Reveal Email/Phone |
4 | Lead Data Scientist | Reveal Email/Phone |
Cairn Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Cairn Biosciences?
Cairn Biosciences is developing next-generation therapeutics that address significant challenges in the treatment of serious diseases. Cairn’s drug discovery engine addresses the profound unmet need for new tools to decipher cellular complexity and enable scalable discovery of groundbreaking therapies. Our proprietary approach enables us to monitor multiple dynamic facets of previously inaccessible biology in live cells and fast-track the discovery of a pipeline of drugs for a wide range of indications with an initial focus on cancer. Cairn 'kern a stone beacon marking the direction of a trail.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 11 | -8% | $20M |
#2 | $0.4M | 11 | -27% | $34M |
#3 | $1M | 11 | N/A | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $1M | 11 | N/A | N/A |